Back to Search
Start Over
INTERIM RESULTS OF A PHASE 3b, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL EVALUATING 24-MONTH SAFETY OF ELAGOLIX WITH ADD-BACK FOR HEAVY MENSTRUAL BLEEDING ASSOCIATED WITH UTERINE FIBROIDS.
- Source :
-
Fertility & Sterility . 2022 Supplement, Vol. 118 Issue 4, pe50-e51. 2p. - Publication Year :
- 2022
- Subjects :
- *MENORRHAGIA
*UTERINE fibroids
*UTERINE hemorrhage
*UTERINE artery
*MYOMECTOMY
Subjects
Details
- Language :
- English
- ISSN :
- 00150282
- Volume :
- 118
- Issue :
- 4
- Database :
- Academic Search Index
- Journal :
- Fertility & Sterility
- Publication Type :
- Academic Journal
- Accession number :
- 159845133
- Full Text :
- https://doi.org/10.1016/j.fertnstert.2022.08.161